Journal for ImmunoTherapy of Cancer (Oct 2021)

Correction: Real-life use of talimogene laherparepvec (T-VEC) in melanoma patients in centers in Austria, Switzerland and Germany

DOI
https://doi.org/10.1136/jitc-2020-001701corr1
Journal volume & issue
Vol. 9, no. 10

Abstract

Read online

No abstracts available.